Health TrialsbyHealthPanel

Telehealth-Based Chronic Disease Management for Type 2 Diabetes

ConditionType 2 DM
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorZeng Lin, Ph. D.

About this trial

This study will be conducted from enrollment until the end of the six-month follow-up period.

This study aims to assess the impact of the Internet hospital online + offline integrated chronic disease management model on patients with type 2 diabetes mellitus. It will also evaluate the economic impact of the model and identify the characteristics of the appropriate population for the model. Finally, it will develop a toolkit to help manage chronic diseases.

The study will include 1,636 patients with type 2 diabetes who did not reach the standard of control target of glucose, blood pressure or LDL at the endocrine outpatient clinic and inpatient wards of the Third Hospital of Peking University. We will collect information from participants before the study starts. And the patients will be followed up for 6 months from enrollment. The study management mode included online and offline integrated management in the Internet hospital, and routine offline management mode. After completing the enrollment and assessment, we will arrange outpatient follow-up and management according to the current status, doctor's requirements, and study subjects' needs.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

18-70 years old;

Confirmed diagnosis of type 2 diabetes mellitus;

Ability to use smartphones to participate in online diagnosis and treatment;

Ability of the patient or relatives to assist the patient in self-monitoring of blood glucose;

Disqualifiers

Mental illness, cognitive dysfunction;

Other diseases and complex conditions (untreated tumors, heart disease within 3 months);

Acute complications of diabetes, severe hyperglycemia, fasting glucose greater than 16.9 mmol / L, random glucose greater than 20 mmol / L. Diabetic ketoacidosis and hypoglycemic coma that are not suitable for online management of diabetes emergencies;

Patients with severe chronic complications of diabetes in critical condition (blindness, vision deterioration, new onset of ASCVD symptoms);

Trial population

The study will include patients with type 2 diabetes who did not meet the control target of glucose, blood presure or LDL at the endocrine outpatient clinic and inpatient wards of the Third Hospital of Peking University.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

1,636 Participants
are grouped into 2 trial groups
Group A: online + offline integrated management in the Internet hospital
Group B: Routine offline management mode

Trial outcomes

Primary outcomes

1

the proportion of patients achieved all three targets (HbA1c < 7.0%, blood pressure < 130/80 mmHg and LDL-cholesterol < 2.6 mmol/L)

Time frame
at 6±1 month from the enrollment

Secondary outcomes

1

patient adherence using 8-item Morisky Medication Adherence Scale (MMAS-8)

Time frame
at 3±1 month from the enrollment
2

patient satisfaction using Visual Analogue Scale (VAS)

Time frame
at 3±1 month from the enrollment
3

Hypoglycemic events

Time frame
at 3±1 month from the enrollment
4

Acute complications

Time frame
at 3±1 month from the enrollment

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Zeng Lin, Ph. D.

Lead sponsor

Peking University Third Hospital

Sponsor institution

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: